Location: Naarden, Netherlands
CIK: 0002013410 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $750M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 8,490,353 | $288M | 38.3% | — | — | ORDINARY SHARES | N62509109 |
| MPLT | MAPLIGHT THERAPEUTICS INC | 3,226,400 | $116M | 15.4% | — | — | COM | 56565P103 |
| DYN | DYNE THERAPEUTICS INC | 3,848,256 | $85.47M | 11.4% | — | — | COM | 26818M108 |
| VOR | VOR BIOPHARMA INC | 4,117,354 | $75.8M | 10.1% | — | — | COM NEW | 929033207 |
| GLTO | DAMORA THERAPEUTICS INC | 2,441,000 | $63.49M | 8.5% | — | — | COM NEW | 36322Q206 |
| REPL | REPLIMUNE GROUP INC | 2,808,368 | $31.09M | 4.1% | — | — | COM | 76029N106 |
| CBIO | CRESCENT BIOPHARMA INC. | 1,677,852 | $30.2M | 4.0% | — | — | COM | G2545C104 |
| AURA | AURA BIOSCIENCES INC | 4,053,775 | $28.78M | 3.8% | — | — | COM | 05153U107 |
| ENGN | ENGENE HOLDINGS INC | 9,632,561 | $16.66M | 2.2% | — | — | COM | 29286M105 |
| BCYC | BICYCLE THERAPEUTICS PLC | 3,468,430 | $14.71M | 2.0% | — | — | SPONSORED ADS | 088786108 |
| ENGNW | ENGENE HOLDINGS INC | 2,878,148 | $834K | 0.1% | — | — | W EXP 10/31/2028 | 29286M113 |